Medik8 Blemish SOS | Rapid Action Spot Treatment | 15ml

Product Overview - Medik8 Blemish SOS™ | Rapid Action Spot Treatment | 15ml. Medik8 Blemish SOS™ is a professional-grade rapid action spot treatment gel expertly formulated to target individual blemishes with precision and speed. This targeted treatment features maximum strength Salicylic Acid (2%) combined with soothing Niacinamide, antibacterial Azelaic Acid, and sebum-regulating Octadecenedioic Acid to address blemishes at their core whilst remaining completely invisible on the skin.. Designed for blemish-prone, oily, and combination skin types, this fast-drying formula works efficiently both at home and on-the-go, making it the perfect emergency rescue treatment. The lightweight gel texture sinks effortlessly into skin without leaving residue, allowing seamless application under or over makeup. Our experts recommend this clinically-proven formulation for those seeking a professional solution to occasional breakouts or persistent blemish concerns.. Key Benefits at a Glance:. Immediate Benefits:. Rapid visible reduction of blemishes in as little as 24 hours through targeted salicylic acid action. Calms inflammation and visible redness immediately upon application with anti-inflammatory niacinamide. Invisible, fast-drying formula that allows makeup application without interference or residue. Penetrates deep into pores to break down blockages and target blemish-causing bacteria (C. acnes). Controls excess sebum production to prevent future breakouts and minimise pore appearance. Long-Term Benefits:. With consistent use, Blemish SOS™ helps to maintain a clearer, healthier-looking complexion by addressing the root causes of blemish formation. The exfoliating action of salicylic acid works continuously to prevent pore congestion whilst antibacterial azelaic acid reduces the presence of blemish-causing bacteria over time. Regular application supports balanced sebum production, helping to create an environment less conducive to breakouts.. The formulation's gentle yet e